Find a Doctor
To find your closest EVO ICL doctor, start by searching your location.
3+ million lenses distributed worldwide

Sort by:
Office Information
Office Hours
- Today
- 8:00AM - 5:00PM
About this Doctor
Dr. Majid Moshirfar is a board-certified ophthalmologist and fellowship-trained cornea specialist. He is the Clinical Director of Hoopes, Durrie, Rivera Research. An internationally renowned corneal and refractive surgeon, Dr. Moshirfar brings a history of innovation in cornea surgery, a strong background in clinical research, and a prolific legacy of academic teaching, publishing, and speaking. Immediately before joining Hoopes Vision, Dr. Moshirfar spent a year as a Professor of Ophthalmology at the University of California, San Francisco. Prior to that appointment, Dr. Moshirfar served on the faculty of the University of Utah John A. Moran Eye Center for 18 years, including 16 as the Director of Cornea and Refractive Surgery.
Dr. Moshirfar earned his medical degree from the Georgetown University School of Medicine with Alpha Omega Alpha honorary recognition. He completed his ophthalmology residency at Illinois Eye and Ear Hospital in Chicago, where during his final year, he received the Best Resident Award. This was followed by a two-year fellowship with emphasis on cornea and external disease, refractive surgery, and anterior segment reconstruction at the Moran Eye Center. Dr. Moshirfar then established his own cornea fellowship at the Moran Eye Center, one which has become one of the most sought-after fellowship programs in the country, training a total of 38 fellows to date.
Dr. Moshirfar specializes in refractive surgeries and other complex procedures of the cornea and anterior segment of the eye. Dr. Moshirfar has played a leading role in the development and dissemination of these procedures, particularly in the area of challenging refractive surgery techniques. Dr. Moshirfar has authored more than 200 peer-reviewed scientific publications and serves on the editorial boards of numerous scientific journals. He and his wife, Pegah, are parents of two sons and a daughter.
Languages Spoken
- English
- Farsi
Certification and Association
- Director of Cornea and Refractive Surgery, John A. Moran Eye Center, University of Utah
- Clinical Director of Hoopes, Durrie, Rivera Research, Hoopes Vision
- Board Certified Ophthalmologist
- Alpha Omega Alpha
Education
- Fellowship, Moran Eye Center, University of Utah
- Resident, Illinois Eye and Ear Hospital, University of Illinois Chicago
- M.D., Georgetown University
- Professor of Ophthalmology at the University of California, San Francisco
Call today to set up a consultation for EVO ICL
(801) 568-0200Select Your Region
Latin America
References
1. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.
2. Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125.
3. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clinical Ophthalmology. 2022;16:1541-53.
4. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215.
5. Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017;11:1253-1263.
6. Naves J.S, Carracedo G, Cacho-Babillo I, Diadenosine nucleotid measurements as dry-eye score in patients after LASIK and ICL surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
7. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
8. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.
9. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.
This provider locator tool is being provided by STAAR Surgical® Company (“STAAR”) solely to assist users in locating a provider who has experience with the EVO ICL family of lenses, as explained further here. Specifically, the sole criteria for inclusion in the locator is whether a provider is certified by STAAR to implant EVO ICL lenses. Users may search the locator by zip code, state, or current location. Two types of sorting functionality is available within the locator. Users are able to sort the results via distance, or by the frequency with which a healthcare provider has recently used EVO ICL lenses (e.g., within the past 12 months). Irrespective of the sorting method selected, all providers are shown in the results within the queried geographic location. The listed order of providers under any sorting method, including the initial presentation of providers in a geographic location, is based on a variety of factors, including whether the provider maintains consumer-facing information about EVO ICL lenses on its website, the breadth and quality of such information, whether it has demonstrated a commitment to training staff and offering the EVO ICL as a refractive procedure option to qualified patients, and how frequently the provider has performed procedures using the EVO ICL over the past year.
Notwithstanding the above, this provider locator tool should not be construed in any way as an endorsement or recommendation by STAAR as to the qualifications of any provider listed in this tool or the quality of medical care they can provide. STAAR makes no guarantees that using a provider from this list will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential provider. STAAR recommends that you meet and discuss the benefits and risks of the EVO ICL lens, and the procedure to implant the EVO ICL lens with the potential provider.
STAAR hereby disclaims any and all liability arising from your use of and/or reliance on the information contained in this provider locator tool.
Important Safety Information
The EVO Visian ICL Lens is intended for the correction of moderate to high nearsightedness. EVO Visian ICL and EVO Visian TICL surgery is intended to safely and effectively correct nearsightedness between -3.0 D to -15.0 D, the reduction in nearsightedness up to -20.0 D and treatment of astigmatism from 1.0 D to 4.0 D. If you have nearsightedness within these ranges, EVO Visian ICL surgery may improve your distance vision without eyeglasses or contact lenses. Because the EVO Visian ICL corrects for distance vision, it does not eliminate the need for reading glasses, you may require them at some point, even if you have never worn them before.
Implantation of the EVO Visian ICL is a surgical procedure, and as such, carries potentially serious risks. Please discuss the risks with your eye care professional. Complications, although rare, may include need for additional surgical procedures, inflammation, loss of cells from the back surface of the cornea, increase in eye pressure, and cataracts.
You should NOT have EVO Visian ICL surgery if:
- Your doctor determines that the shape of your eye is not an appropriate fit for the EVO Visian ICL
- You are pregnant or nursing
- You have moderate to severe damage to the optic nerve caused by increased pressure (glaucoma)
- You do not meet the minimum endothelial cell density for your age at the time of implantation as determined by your eye doctor
- Your vision is not stable as determined by your eye doctor
Before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery. For additional information with potential benefits, risks and complications please visit DiscoverICL.com.
Feeling unsure?
We get it. Decisions like this take time to consider and research. We can help guide your decision with information that's the most relevant to you.
Do you currently wear glasses or contacts?